By retrospectively analyzing CDK6-AS1 expression in a cohort of 132 pediatric patients harboring several genetic abnormalities, elevated expression of CDK6-AS1 was detected in AML samples as compared to healthy cord-blood derived mononuclear cells. Here, CDK6 is linked to acute myeloid leukemia.